双歧三联活菌胶囊联合多潘立酮治疗FD的临床观察被引量：3

下载PDF

导出

摘要目的评价双歧三联活菌胶囊联合多潘立酮治疗功能性消化不良(FD)的临床疗效。方法治疗组使用双歧三联活菌胶囊联合多潘立酮治疗FD患者45例,对照组单用多潘立酮治疗FD患者45例。结果治疗组和对照组的总有效率分别为91%和42.2%(P<0.05)两组患者治疗后均无明显不良反应。结论双歧三联活菌胶囊联合多潘立酮治疗FD,能使症状有效缓解,是FD治疗安全、有效的方法,比单用多潘立酮有效率明显提高。

作者周国标

机构地区浙江省上虞市第二人民医院消化科

出处《安徽医药》 CAS 2007年第8期696-696,共1页 Anhui Medical and Pharmaceutical Journal

关键词消化不良双歧三联活菌胶囊多潘立酮

分类号 R57 [医药卫生—消化系统]

引文网络
相关文献

参考文献6

1铝碳酸镁治疗非溃疡性消化不良多中心的临床观察[J].中华消化杂志,1999,19(1):53-53. 被引量：33
2Tall NJ,Stanhellini V,Heading RC,et al.functional gastroduodenal disorders[J].Gut,1999,45 (supplⅡ):37-42. 被引量：1
3侯晓华.开展对功能性消化不良的病理生理研究[J].中华消化杂志,2003,23(2):69-70. 被引量：195
4姚希贤主编..临床消化病学[M].天津:天津科学技术出版社,1999:1670.
5李兆申,许国铭,杜奕奇,刘文忠,程能能,萧树东.小剂量奥美拉唑治疗功能性消化不良[J].胃肠病学,2003,8(6):337-339. 被引量：10
6罗永鑫,姚明辉.质子泵抑制剂的进展[J].中国药学杂志,2004,39(9):648-651. 被引量：22

二级参考文献38

1[2]Talley NJ, Meineche-Schmidt V, Pare P, Duckworth M, Raisanen P, Pap A, Kordecki H, Schmid V. Efficacy of omeprazole in functional dyspepsia:double-blind, randomized, placebo-controlled trials (the Bond and Opera studies). Aliment Pharmacol Ther, 1998, 12: 1055～1065. 被引量：1
2[3]Blum AL, Arnold R, Stolte M, Fischer M, Koelz HR. Short course acid suppressive treatment for patients with functional dyspepsia: results depend on Helicobacter pylori status. The Frosch Study Group. Gut, 2000, 47: 473～480. 被引量：1
3[1]Huber R, Kohl B, Sachs G, et al. The continuing development of proton pump inhibitors with particular reference to pantorazole [J]. Aliment Pharmacol Ther , 1995,9:363. 被引量：1
4[2]Blum RA.Lansoprazol and omeprazol in the treatment of acid peptic disorders[J]. Am J Health-Syst Pharm , 1996,53:1401. 被引量：1
5[3]Chiverton SG, Howden CW, Burget DW, et al. Omeprazole (20 mg)daily given in the morning or evening: a comparison of effects on gastric acidity,and plasma gastrin and omeprazole concentration[J] .Aliment Pharmacol Ther,1992,6:103. 被引量：1
6[4]Savarino V, Mela GS, Zentilin P, et al. Variability in individual response to various doses of omeprazole: implication for anti-unlcertherapy[J]. Dig Dis Sci, 1994,39(1):161. 被引量：1
7[5]Bergatrand R.Decreased oral bioavialability of lansoprazole in healthy clunteeres when given with a standardized breakfast[J]. Clin Drug Invest, 1995,9:67. 被引量：1
8[6]Katz PO, Anderson C, Khoury R, et al, Gastro-esophageal reflux associated with nocturnal gastric acid breakthrough on proton pump inhibitors[J]. Aliment Pharmacol Ther , 1998,12:1231. 被引量：1
9[7]Ishizaki T, Horai Y.Cytochrome P450 and the metabolism of proton pump inhibitors-emphasis on rabeprazole [J] . Aliment PharmacolTher, 1999,13 (Suppl 3) :27. 被引量：1
10[8]Dammann HG, Burkhardt F. Pantoprazole versus omeprazole: influence on meal-stimulated gastric acid secretion[J]. Eur J GastroenterolHepatol, 1999,11:1277. 被引量：1